IMIS

Publications | Institutes | Persons | Datasets | Projects | Maps | Infrastructure
[ report an error in this record ]basket (0): add | show Print this page

Cnidarians as a potential source of antiparasitic drugs
Mostafa, O.; Al-Shehri, M.; Moustafa, M.; Al-Emam, A. (2022). Cnidarians as a potential source of antiparasitic drugs. Parasitol. Res. 121(1): 35-48. https://dx.doi.org/10.1007/s00436-021-07387-2
In: Parasitology Research. Springer: Berlin; Heidelberg. ISSN 0932-0113; e-ISSN 1432-1955, more
Peer reviewed article  

Available in  Authors 

Keywords
    Cnidaria [WoRMS]
    Marine/Coastal
Author keywords
    Cnidarians; Antiparasitic; Drugs; Toxins; Extracts

Authors  Top 
  • Mostafa, O.
  • Al-Shehri, M.
  • Moustafa, M.
  • Al-Emam, A.

Abstract
    New antiparasitic drugs are urgently required for treating parasitic infections. The marine environment has proven to be a valuable source of compounds with therapeutic properties against many diseases, including parasitic diseases. Cnidarian venoms are known for their toxicological properties and are candidates for developing medications. In this review, the antiparasitic properties of cnidarian toxins, discovered over the last two decades, were examined. A total of 61 cnidarian compounds from 18 different genera of cnidaria were studied for their antiparasitic activities. The assessed genera belonged mainly to three geographical areas: South America, North America, and Southeast Asia. The in vitro activities of crude extracts and compounds against a range of parasites including Plasmodium falciparum, Trypanosoma brucei gambiense, T. cruzi, T. congolense, Leishmania donovani, L. chagasi, L. braziliensis, and Giardia duodenalis are reviewed. The challenges involved in developing these compounds into effective drugs are discussed.

All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors